[ursAxZA]

Thanks.

Outside weight-class or aesthetics-driven sports, it’s hard to imagine any scenario where a GLP-1 analog creates a net advantage.

In endurance disciplines the binding constraint is almost always fuel throughput: if an athlete can’t take in and process enough calories, recovery and performance fall apart. Anything that suppresses appetite or slows gastric motility is basically disqualifying.

You can already see how narrow that margin is in the sheer amount of gels, bars, and mixes riders consume during long sessions. From that angle, GLP-1 simply doesn’t occupy the same decision space as substances that expand performance capacity or recovery bandwidth.